Rajesh Khanna

Affiliations: 
 
Area:
Ion channel transport, presynaptic proteins
Google:
"Rajesh Khanna"
Mean distance: 15.18 (cluster 11)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Duran P, Loya-López S, Ran D, et al. (2022) The natural product Argentatin C attenuates postoperative pain via inhibition of voltage-gated sodium and T-type voltage-gated calcium channels. British Journal of Pharmacology
Gomez K, Tang C, Tan B, et al. (2022) Stereospecific Effects of Benzimidazolonepiperidine Compounds on T-Type Ca Channels and Pain. Acs Chemical Neuroscience
François-Moutal L, Scott DD, Ambrose AJ, et al. (2022) Heat shock protein Grp78/BiP/HspA5 binds directly to TDP-43 and mitigates toxicity associated with disease pathology. Scientific Reports. 12: 8140
Ito H, Navratilova E, Vagnerova B, et al. (2022) Chronic pain recruits hypothalamic dynorphin/kappa opioid receptor signalling to promote wakefulness and vigilance. Brain : a Journal of Neurology
Kong X, Li Y, Perez-Miller S, et al. (2022) The small molecule compound C65780 alleviates pain by stabilizing voltage-gated sodium channels in the inactivated and slowly-recovering state. Neuropharmacology. 109057
Watanabe M, Kopruszinski CM, Moutal A, et al. (2022) Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine. Brain : a Journal of Neurology
Goins AE, Gomez K, Ran D, et al. (2022) Neuronal allodynic mechanisms of Slc7a5 (LAT1) in the spared nerve injury rodent model of neuropathic pain. Pflugers Archiv : European Journal of Physiology
Boinon L, Yu J, Madura CL, et al. (2022) Conditional knockout of CRMP2 in neurons, but not astrocytes, disrupts spinal nociceptive neurotransmission to control the initiation and maintenance of chronic neuropathic pain. Pain. 163: e368-e381
Braden K, Stratton HJ, Salvemini D, et al. (2022) Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces and prevents pain chronification in a mouse model of oxaliplatin-induced neuropathic pain. Neurobiology of Pain (Cambridge, Mass.). 11: 100082
Li J, Stratton HJ, Lorca SA, et al. (2022) Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in chronic constriction injury (CCI) rats. Channels (Austin, Tex.). 16: 1-8
See more...